Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Open-label Comparison of Preoperative Weekly Paclitaxel and Cisplatin With or Without Endocrine Therapy in Patients With Operable Hormone Receptor Positive and Triple Negative Locally Advanced Breast Cancer

NCT02221999 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT02221999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02221999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Open-label Comparison of Preoperative Weekly Paclitaxel and Cisplatin With or Without Endocrine Therapy in Patients With Operable Hormone Receptor Positive and Triple Negative Locally Advanced Breast Cancer
Lead sponsor
RenJi Hospital
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
September 30, 2013
Completion date
January 31, 2029
Enrollment
250 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory breast cancer, invasive ductal breast cancer, mucinous breast cancer, tubular breast cancer